Zoetis (ZTS) Operating Income Growth (5y) (2017 - 2026)
Zoetis (ZTS) Operating Income Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.35% |
| Dec 31, 2025 | 8.86% |
| Sep 30, 2025 | 8.37% |
| Jun 30, 2025 | 23.59% |
| Mar 31, 2025 | 11.31% |
| Dec 31, 2024 | 66.06% |
| Sep 30, 2024 | 21.90% |
| Jun 30, 2024 | 18.92% |
| Mar 31, 2024 | 15.95% |
| Dec 31, 2023 | 53.74% |
| Sep 30, 2023 | 31.98% |
| Jun 30, 2023 | 30.75% |
| Mar 31, 2023 | 29.45% |
| Dec 31, 2022 | 119.14% |
| Sep 30, 2022 | 28.87% |
| Jun 30, 2022 | 30.27% |
| Mar 31, 2022 | 29.77% |
| Dec 31, 2021 | 37.49% |
| Sep 30, 2021 | 65.45% |
| Jun 30, 2021 | 59.90% |